134 results
6-K
EX-10.3
BLRX
Bioline Rx Ltd
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
continuing is a reference to an Event of Default that has not been remedied to the satisfaction of the Lender; and
the headings in this Loan Agreement … ) of the Loan
Subject to Clause 3.1.3, (and subject to the satisfaction of the relevant conditions set forth in Clause 3.5), the Tranche shall
6-K
EX-99
BLRX
Bioline Rx Ltd
15 Sep 22
Current report (foreign)
8:39am
continuing is a reference to an Event of Default that has not been remedied to the satisfaction of the Lender; and
the headings in this Loan Agreement … (and subject to the satisfaction of the relevant conditions set forth in Clause 3.5), each Tranche drawn by the Borrower shall be advanced and made available
20FR12B
EX-4.14
BLRX
Bioline Rx Ltd
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
), operating results or business of the Company;
any waiver by the Company of a valuable right or of a material debt owed to it;
any satisfaction … and financial condition of the Company) and has received, to its satisfaction, answers to all such questions. The Lender has independently evaluated
F-1
EX-10.14
fejk2auk5m
24 Sep 10
Registration statement (foreign)
12:00am
6-K
EX-99.1
9y3w5axvd 0y
13 Feb 13
BioLineRx Announces Closing of $8 Million Offering of American
12:00am
F-3/A
EX-4.2
lwxl5nr286z
13 Aug 12
Shelf registration (foreign) (amended)
12:00am
S-8
EX-5.1
nfmq 31bk
29 Dec 23
Registration of securities for employees
4:20pm
6-K
EX-5.1
2mo1u9lou8mqyih0
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
FWP
ghyk1bl7919jhymfed37
19 Jan 21
Free writing prospectus
5:01pm
6-K
EX-99.2
dv6qj4yo9 74
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
7jtlrwsiozawr
4 Feb 13
Current report (foreign)
12:00am
6-K
EX-5.2
jvs2i
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
6-K
EX-5.2
evr90vfru1rrjx1rsgs
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-99
9my2 luj2yrtfqlxnj3g
26 May 20
BioLineRx Announces $9.0 Million Registered Direct Offering
8:45am
F-3
EX-5.1
ftoh4dpz
29 Dec 23
Shelf registration (foreign)
4:15pm
20FR12B
EX-4.23
b00 ymlg4qym9
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
6-K
EX-99
3l17j4x33 811zgm1q
1 Jun 20
BioLineRx Announces $4.39 Million Registered Direct Offering
8:05am
6-K
poq96yr8
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am